KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Shares Repurchased (2017 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Shares Repurchased for 9 consecutive years, with $53.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Repurchased fell 45.45% to $53.4 million in Q3 2025 year-over-year; TTM through Dec 2025 was $295.5 million, a 45.14% increase, with the full-year FY2025 number at $295.5 million, up 45.14% from a year prior.
  • Shares Repurchased was $53.4 million for Q3 2025 at Bio-Rad Laboratories, down from $140.2 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $207.4 million in Q2 2023 to a low of $4.7 million in Q1 2024.
  • A 5-year average of $99.5 million and a median of $99.4 million in 2024 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: crashed 51.3% in 2024, then soared 2068.09% in 2025.
  • Bio-Rad Laboratories' Shares Repurchased stood at $50.0 million in 2021, then skyrocketed by 81.41% to $90.7 million in 2022, then skyrocketed by 120.48% to $200.0 million in 2023, then plummeted by 51.04% to $97.9 million in 2024, then crashed by 45.45% to $53.4 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Shares Repurchased are $53.4 million (Q3 2025), $140.2 million (Q2 2025), and $101.9 million (Q1 2025).